Annual CFI
$7.78 M
-$66.28 M-89.50%
December 31, 2023
Summary
- As of February 10, 2025, LABP annual cash flow from investing activities is $7.78 million, with the most recent change of -$66.28 million (-89.50%) on December 31, 2023.
- During the last 3 years, LABP annual CFI has fallen by -$6.36 million (-44.98%).
Performance
LABP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$0.00
-$63.00 K-100.00%
March 31, 2024
Summary
- As of February 10, 2025, LABP quarterly cash flow from investing activities is $0.00, with the most recent change of -$63.00 thousand (-100.00%) on March 31, 2024.
- Over the past year, LABP quarterly CFI has dropped by -$634.00 thousand (-100.00%).
Performance
LABP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
$4.67 M
-$3.10 M-39.92%
March 31, 2024
Summary
- As of February 10, 2025, LABP TTM cash flow from investing activities is $4.67 million, with the most recent change of -$3.10 million (-39.92%) on March 31, 2024.
- Over the past year, LABP TTM CFI has dropped by -$14.51 million (-75.65%).
Performance
LABP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
LABP Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.5% | -100.0% | -75.7% |
| 3 y3 years | -45.0% | +100.0% | +107.8% |
| 5 y5 years | +10000.0% | - | - |
LABP Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.5% | -855.1% | -100.0% | at low | -93.7% | -1356.8% |
| 5 y | 5-year | -89.5% | -855.1% | -100.0% | <-9999.0% | -93.7% | -1404.6% |
| alltime | all time | -89.5% | -855.1% | -100.0% | <-9999.0% | -93.7% | -1404.6% |
Landos Biopharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $0.00(-100.0%) | $4.67 M(-39.9%) |
| Dec 2023 | $7.78 M(-89.5%) | $63.00 K(-90.1%) | $7.78 M(-59.5%) |
| Sep 2023 | - | $634.00 K(-84.0%) | $19.18 M(-46.4%) |
| Jun 2023 | - | $3.97 M(+28.0%) | $35.76 M(-38.0%) |
| Mar 2023 | - | $3.10 M(-72.9%) | $57.66 M(-22.1%) |
| Dec 2022 | $74.06 M(-226.2%) | $11.47 M(-33.4%) | $74.06 M(+15.0%) |
| Sep 2022 | - | $17.21 M(-33.5%) | $64.39 M(+11.0%) |
| Jun 2022 | - | $25.87 M(+32.6%) | $58.00 M(+76.6%) |
| Mar 2022 | - | $19.51 M(+986.1%) | $32.85 M(-156.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$58.71 M(-515.4%) | $1.80 M(-83.4%) | -$58.71 M(+9.6%) |
| Sep 2021 | - | $10.83 M(+1414.8%) | -$53.57 M(-12.1%) |
| Jun 2021 | - | $715.00 K(-101.0%) | -$60.94 M(+2.2%) |
| Mar 2021 | - | -$72.05 M(-1139.7%) | -$59.62 M(-521.9%) |
| Dec 2020 | $14.13 M(-135.0%) | $6.93 M(+100.1%) | $14.13 M(+96.2%) |
| Sep 2020 | - | $3.46 M(+70.6%) | $7.20 M(+92.7%) |
| Jun 2020 | - | $2.03 M(+18.9%) | $3.74 M(+118.9%) |
| Mar 2020 | - | $1.71 M | $1.71 M |
| Dec 2019 | -$40.33 M(>+9900.0%) | - | - |
| Dec 2018 | -$43.00 K | - | - |
FAQ
- What is Landos Biopharma annual cash flow from investing activities?
- What is the all time high annual CFI for Landos Biopharma?
- What is Landos Biopharma annual CFI year-on-year change?
- What is Landos Biopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Landos Biopharma?
- What is Landos Biopharma quarterly CFI year-on-year change?
- What is Landos Biopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Landos Biopharma?
- What is Landos Biopharma TTM CFI year-on-year change?
What is Landos Biopharma annual cash flow from investing activities?
The current annual CFI of LABP is $7.78 M
What is the all time high annual CFI for Landos Biopharma?
Landos Biopharma all-time high annual cash flow from investing activities is $74.06 M
What is Landos Biopharma annual CFI year-on-year change?
Over the past year, LABP annual cash flow from investing activities has changed by -$66.28 M (-89.50%)
What is Landos Biopharma quarterly cash flow from investing activities?
The current quarterly CFI of LABP is $0.00
What is the all time high quarterly CFI for Landos Biopharma?
Landos Biopharma all-time high quarterly cash flow from investing activities is $25.87 M
What is Landos Biopharma quarterly CFI year-on-year change?
Over the past year, LABP quarterly cash flow from investing activities has changed by -$634.00 K (-100.00%)
What is Landos Biopharma TTM cash flow from investing activities?
The current TTM CFI of LABP is $4.67 M
What is the all time high TTM CFI for Landos Biopharma?
Landos Biopharma all-time high TTM cash flow from investing activities is $74.06 M
What is Landos Biopharma TTM CFI year-on-year change?
Over the past year, LABP TTM cash flow from investing activities has changed by -$14.51 M (-75.65%)